Skip to main content
. 2021 Jul 12;95(15):e00294-21. doi: 10.1128/JVI.00294-21

TABLE 5.

Primers and oligonucleotides used in this study

Pool for enrichment (method) or primera Sequence (5′→3′)b
T7-P5-VSP pool (1) TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTcactgctatgtttagtgttc
TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTcaacataagagaacacacag
TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTtgcttttcactcttcatttc
TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTaaacctagatgtgctgatg
TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTgtgtgaaggtattgtttgtt
TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTtttttgtcctttttaggctc
TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTctttaccagacattttgctc
TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTatctttcattttaccgtcac
TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTgttctccattctggttactg
TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTgtgctatgtagttacgagaa
TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTatagaagtgaataggacacg
TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTtcaagtcctccctaatgtt
TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTattggttgctcttcatctaa
TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTgtctgaaagaagcaatgaag
TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTagaggatgaaatggtgaatt
TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTcaagtgagaaccaaaagataa
TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTgagtaaacgtaaaaagaaggt
TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTaagccaaagcctcattatta
TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTaatctactgatgtcttggtc
TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTcctttccacaaaaatcaact
TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTtaatcagcaatctttccagt
TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTacagaaagtagtgaaaccat
TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTcaaaataggcatacaccatc
TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTctttccatccaacttttgtt
TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTttctgtgtaactccaatacc
TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTaaacccacttctcttgttat
TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTtgggtggtttatgtgattta
TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTggtcaaggttaatataggca
TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTtacgtccattcataccattt
P7-N6 GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTNNNNNN
P7-VSP pool (2) GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTgaacactaaacatagcagtg
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTctgtgtgttctcttatgttg
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTgaaatgaagagtgaaaagca
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTcatcagcacatctaggttt
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTaacaaacaataccttcacac
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTgagcctaaaaaggacaaaaa
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTgagcaaaatgtctggtaaag
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTgtgacggtaaaatgaaagat
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTcagtaaccagaatggagaac
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTtctcgtaactacatagcac
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTcgtgtcctattcacttctat
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTaacattagggaggacttga
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTttagatgaagagcaaccaat
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTcttcattgcttctttcagac
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTaattcaccatttcatcctct
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTttatcttttggttctcacttg
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTaccttctttttacgtttactc
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTtaataatgaggctttggctt
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTgaccaagacatcagtagatt
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTagttgatttttgtggaaagg
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTactggaaagattgctgatta
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTatggtttcactactttctgt
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTgatggtgtatgcctattttg
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTaacaaaagttggatggaaag
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTggtattggagttacacagaa
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTataacaagagaagtgggttt
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTtaaatcacataaaccaccca
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTtgcctatattaaccttgacc
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTaaatggtatgaatggacgta
T7-P5-dT TAATACGACTCACTATAGGGATACCACCATGGCTCTTTCCCTACACGACGCTCTTCCGATCTtttttttttttttttttt
a

Oligonucleotides used in viral-fragment enrichment method 1 and 2, respectively. P7, Illumina primer; VSP, SARS-CoV-2-specific primer; P5, Illumina primer; T7, T7 promoter for in vitro transcription; N6, random hexamer; dT, oligo(dT).

b

Lowercase letters represent virus specific primers/regions.